lptx  stock quote for leap therapeutics inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices leap therapeutics inc nasdaq lptx us markets open adchoices  ▲   after hours     july    pm edt delayed  minutes source nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news christopher k mirabelli phd bloomberg  days ago company overview of leap therapeutics inc bloomberg  leap therapeutics added to russell microcap® index nasdaq  leap therapeutics added to russell microcap® index morning star  leap therapeutics to acquire macrocure the pharma letter  active stocks decreasing in market value – ocul msm aldr tkat carv lptx fx pips  leap therapeutics added to russell microcap® index einpresswirecom  leap therapeutics added to russell microcap® index kten  leap therapeutics added to russell microcap® index wboc  leap therapeutics added to russell microcap® index  abc kaitcom  comerica inc nysecma institutional investor sentiment up to  healthcaremenunet  us stocks on the moveca inc red hat amd foot locker lazboy winnebago and oil stocks times of india  briefleap therapeutics says merck will sponsor and fund initial trials of their combo drug study reuters  briefleap therapeutics says merck will sponsor and fund initial trials of their combo drug study reuters  briefleap therapeutics says merck will sponsor and fund initial trials of their combo drug study mrk marketsinsidercom  briefleap therapeutics says merck will sponsor and fund initial trials of their combo drug study business insider  leap therapeutics  announces collaboration with merck  traders  leap therapeutics announces collaboration with merck to evaluate keytruda® pembrolizumab in combination with dkn in esophagogastric cancer einpresswirecom  adchoices adchoices adchoices markets dow dow ▲    last updated time   pm edt markets nasdaq nasdaq ▲    ftse  ftse  ▲    nyse composite nyse composite ▲    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support leap therapeutics  immunooncology leap therapeutics is a clinicalstage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research  view latest company presentation two firstinclass antibodies our most advanced clinical programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and proliferate known as cancer cell signaling and pathways that enable body’s immune system to identify and attack cancer learn more experienced leadership successful leadership and development team working together for over  years comprehensive experience acquiring and developing approved transformational therapies learn more recent news   more news for patients therapies targeting cancer cell signaling and t cells may offer new options for patients with cancer learn more about management board of directors scientific advisory board pipeline science modulate wnt signaling immunooncology publications for patients investors stock information stock quote  chart historical price lookup news  events news releases events calendar financial information corporate governance documents management board of directors committee composition investor resources information request careers contact about management board of directors scientific advisory board pipeline science modulate wnt signaling immunooncology publications for patients investors stock information stock quote  chart historical price lookup news  events news releases events calendar financial information corporate governance documents management board of directors committee composition investor resources information request careers contact   leap therapeutics incall rights reservedwebsite design hane chow inc leap therapeutics inc company profile  bloomberg feedback leap therapeutics inc public company company profile sector health care industry biotech  pharma subindustry biotech leap therapeutics inc operates as a clinicalstage biopharmaceutical company the company develops novel therapeutics for the treatment of cancer leap therapeutics serves customers worldwide corporate information address  thorndike street suite b cambridge ma  united states phone  fax  web url wwwleaptxcom from the web press releases leap therapeutics added to russell microcap® index jun   leap therapeutics announces collaboration with merck to evaluate keytruda® pembrolizumab in combination with dkn in esoph jun   leap therapeutics to present at two investor conferences in june jun   leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asc may   leap therapeutics reports first quarter  financial results may   leap therapeutics to present dkn clinical data at american society of clinical oncology asco  annual meeting apr   leap therapeutics presents nonclinical and phase  data for trx and dkn at the  aacr annual meeting apr   leap therapeutics reports full year  financial results and progressionfree survival data in advanced biliary tract cancers mar   sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data leap therapeutics inc competitors  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  lptx  competitors leap therapeutics inc competitors lptx        get lptx alerts delayed  data as of jul    et    find a broker to begin trading lptx now exchangenasdaq industry health care community rating view    lptx real time lptx     edit symbol list symbol lookup real time nls trade reporting flashquotes infoquotes summary quote charts interactive charts premarket charts after hours charts revenue  eps summary company financials  view competitors  short interest company news press releases company news press releases sentiment analyst stock research stock report sec filings  holdingsinsider summary  institutional holdings  insider form  equity options premarket quotes after hours quotes company research  stockconsultant stock comparison  guru analysis annual report historical quotes call transcripts dividend history lynch analysis graham analysis validea momentum analysis fool analysis dreman analysis zweig analysis fisher analysis oshaughnessy analysis etf detail etf profile comparison charts symbol list views flashquotes infoquotes stock details summary quote realtime quote after hours quote premarket quote historical quote option chain charts basic chart interactive chart company news company headlines press releases market stream stock analysis analyst research guru analysis stock report competitors stock consultant stock comparison fundamentals call transcripts annual report income statement revenueeps sec filings short interest dividend history holdings ownership summary institutional holdings insiderssec form  closex edit symbol list enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages go now clear list dont know the stock symbol use the symbol lookup tool alphabetize the sort order of my symbols closex   symbol lookup closex investing just got easier… sign up now to become a nasdaqcom member and begin receiving instant notifications when key events occur that affect the stocks you follow access now  save stocks competitor industry biotechnology biological products no diagnostic substances leap therapeutics inc companyname ▲ symbol market lastsale netchange volume todays high  low  weeks high  low p  e ratio market cap acceleron pharma incxlrn nasdaqgm    ▼        ne  acorda therapeutics incacor nasdaqgs    ▲        ne  adaptimmune therapeutics plcadap nasdaqgs    ▼        ne  adma biologics incadma nasdaqcm    ▼        ne  adverum biotechnologies incadvm nasdaqgm    ▼        ne  aerie pharmaceuticals incaeri nasdaqgm    ▼        ne  aevi genomic medicine incgnmx nasdaqgm    ▼        ne  agenus incagen nasdaqcm    ▼        ne  amgen incamgn nasdaqgs    ▼          ampliphi biosciences corporationaphb amex    ▼        ne  apollo endosurgery incapen nasdaqgm    ▲        ne  applied genetic technologies corporationagtc nasdaqgm    ▲          aptose biosciences incapto nasdaqcm    ▼        ne  argenx seargx nasdaqgs    ▼        ne  asterias biotherapeutics incast amex    ▲        ne  atara biotherapeutics incatra nasdaqgs    ▼        ne  atyr pharma inclife nasdaqgs    ▼        ne  audentes therapeutics incbold nasdaqgm    ▼        ne  avexis incavxs nasdaqgs    ▲        ne  aviragen therapeutics incavir nasdaqgs    ▲        ne  biocryst pharmaceuticals incbcrx nasdaqgs    ▼        ne  biogen incbiib nasdaqgs    ▼          biondvax pharmaceuticals ltdbvxv nasdaqcm    ▼        ne  biondvax pharmaceuticals ltdbvxvw nasdaqcm    ▼        ne  biotechne corptech nasdaqgs    ▼           first previousnext last  closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex leap therapeutics inc lptxoq company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile leap therapeutics inc lptxoq related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse lptxoq on nasdaq stock exchange global market usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description leap therapeutics inc formerly healthcare pharmaceuticals inc is a clinicalstage biopharmaceutical company the company engages in acquiring and developing therapeutics in cancer biology leaps programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the bodys immune system to identify and attack cancer the companys lead product candidates for use in clinical trials include trx and dkn dkn is a monoclonal antibody targeting dickkopfrelated protein  dkk dkk serves as the inhibitors of the canonical wnt signaling pathway and modulates the noncanonical wnt signaling pathways when dkn binds to dkk wnt signaling pathways and the tumor microenvironment are altered and an antitumor effect can be generated the company is testing dkn in ongoing clinical trials in patients with esophageal cancer in combination with paclitaxel and in patients with cholangiocarcinoma in combination with gemcitabine and cisplatin the company has studied dkn as a monotherapy in patients with nonsmall cell lung cancer nsclc dknbased therapies have generated responses and clinical benefit in these patient populationsdkn has potential as a targeted cancer treatment in other tumor types such as pancreatic gastric liver head and neck uterine and prostate cancers and multiple myeloma dkn has been tested as a monotherapy in patients with nsclc and in a pilot study in patients with multiple myeloma in combination with lenalidomide and dexamethasone trx is a monoclonal antibody targeting the glucocorticoidinduced tumor necrosis factorrelated receptor gitr a receptor found on the surface of a range of immune cells trx has been engineered to enhance the immune systems antitumor response by activating gitr signaling or gitr agonism to activate tumor fighting white blood cells or t effector cells and decrease the activity of potentially tumorprotective white blood cells or t regulatory cells without causing the immune cells to be destroyed the company is conducting two clinical trials of trx in patients with advanced solid tumors and have evidence of biomarker modulation and clinical activitythe company competes with novartis ag merck  co pfizer inc bristolmyers squibb company astrazeneca plc agenus inc and incyte corporation » full overview of lptxoq company address leap therapeutics inc  thorndike st ste bcambridge   ma    p f  company web links home page officers  directors » more officers  directors leap therapeutics inc news briefleap therapeutics says merck will sponsor and fund initial trials of their combo drug study jun   briefleap therapeutics announces collaboration with merck jun   » more lptxoq news related topics stocksstock screenerhealthcarebiotechnology  medical research lptx stock price  leap therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers fcx  rrc  nem  sig  stx  ipg  wat  mmm  latest newsall times eastern p updated sen angus king’s silent synopsis of the healthcare legislation up for vote today p updated gold extends declines to a second session as investors await fed update p charting a slowmotion summer breakout sp  confirms bull trend p updated why vix is flirting with its lowest level in history and how wall street is reacting p the highest paid athletes in the world in one chart p updated european stocks finish higher as german businesses take ‘euphoric’ tone p updated brits don’t want america’s chlorinated chickens in their supermarkets p debtceiling fears bubble up in treasury bills a opinion here’s one trump fan who might make you some money a updated ftse  ends higher as commodity stocks climb factory production roars to be replaced home investing quotes stocks united states lptx overview compare quotes stock screener earnings calendar sectors nasdaq lptx us nasdaq join td ameritrade find a broker leap therapeutics inc watchlist createlptxalert open last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps na yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  recent news marketwatch other dow jones leap therapeutics started at buy with  stock price target at ladenburg thalmann mar   at  am et by tomi kilgore no headlines available recent news other news press releases leap therapeutics to explore the potential of dknkeytruda combo in treatment resistant esophagogastric cancers shares ahead  leap therapeutics to explore the potential of dknkeytruda combo in treatment resistant esophagogastric cancers shares ahead  jun   at  am et on seeking alpha leap therapeutics lptx presents at jefferies  global healthcare conference  slideshow leap therapeutics lptx presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha  things in biotech you should learn today may    things in biotech you should learn today may   may   at  pm et on seeking alpha q leap therapeutics inc q leap therapeutics inc may   at  am et on edgar online  edg  q k k leap therapeutics inc mar   at  pm et on edgar online  edg  q k premarket analyst action  healthcare mar   at  am et on seeking alpha leap therapeutics added to russell microcapr index leap therapeutics added to russell microcapr index jun   at  am et on globenewswire leap therapeutics announces collaboration with merck to evaluate keytrudar pembrolizumab in combination with dkn in esophagogastric cancer leap therapeutics announces collaboration with merck to evaluate keytrudar pembrolizumab in combination with dkn in esophagogastric cancer jun   at  am et on globenewswire leap therapeutics to present at two investor conferences in june leap therapeutics to present at two investor conferences in june jun   at  am et on globenewswire leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asco  annual meeting leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asco  annual meeting may   at  pm et on globenewswire leap therapeutics reports first quarter  financial results leap therapeutics reports first quarter  financial results may   at  am et on globenewswire leap therapeutics to present dkn clinical data at american society of clinical oncology asco  annual meeting apr   at  pm et on globenewswire leap therapeutics presents nonclinical and phase  data for trx and dkn at the  aacr annual meeting apr   at  am et on globenewswire leap therapeutics reports full year  financial results and progressionfree survival data in advanced biliary tract cancers mar   at  pm et on globenewswire leap therapeutics to present at two investor conferences in april mar   at  am et on globenewswire leap therapeutics to present at  barclays global healthcare conference mar   at  am et on globenewswire leap therapeutics to present preclinical and clinical data at  aacr annual meeting mar   at  pm et on globenewswire leap therapeutics to present at th annual bio ceo  investor conference feb   at  am et on globenewswire leap therapeutics presents biomarker and efficacy data at the cholangiocarcinoma foundation  annual meeting feb   at  am et on globenewswire leap therapeutics and macrocure complete merger transaction jan   at  am et on globenewswire macrocure and leap therapeutics complete merger jan   at  am et on pr newswire  prf leap therapeutics presents biomarker data from clinical study of dkn in combination with paclitaxel in esophageal cancer jan   at  pm et on globenewswire leap therapeutics inc engages in clinical stage immunooncology see full profile benzingas top upgrades downgrades for march   mar   at  am et on benzingacom benzingas top upgrades downgrades for march   mar   at  am et on benzingacom partner content trending tickers powered by aks  goog  snap  fcx  dwt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest psen angus king’s silent synopsis of the healthcare legislation up for vote today pgold extends declines to a second session as investors await fed update pcharting a slowmotion summer breakout sp  confirms bull trend pwhy vix is flirting with its lowest level in history and how wall street is reacting pthe highest paid athletes in the world in one chart peuropean stocks finish higher as german businesses take ‘euphoric’ tone pbrits don’t want america’s chlorinated chickens in their supermarkets pdebtceiling fears bubble up in treasury bills ahere’s one trump fan who might make you some money aftse  ends higher as commodity stocks climb factory production roars athis quant pro and card counter says gambling can make you a better investor apopular financial etf poised for best daily gain since late june aelon musk mark zuckerberg spar on ai adebtceiling fears bubble up in treasury bills ajack bogle is right dont be a passive investor be a frugal investor asp  jumps to record on bullish earnings but alphabet weighs on nasdaq awti oil prices trade near the sessions highs on nymex asept wti oil climbs by  or  to bbl athe shockingly subdued vix doesn’t mean what you think it means atrump hammered on twitter over the tenor of his address to boy scouts loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest psen angus king’s silent synopsis of the healthcare legislation up for vote today pgold extends declines to a second session as investors await fed update pcharting a slowmotion summer breakout sp  confirms bull trend pwhy vix is flirting with its lowest level in history and how wall street is reacting pthe highest paid athletes in the world in one chart peuropean stocks finish higher as german businesses take ‘euphoric’ tone pbrits don’t want america’s chlorinated chickens in their supermarkets pdebtceiling fears bubble up in treasury bills ahere’s one trump fan who might make you some money aftse  ends higher as commodity stocks climb factory production roars athis quant pro and card counter says gambling can make you a better investor apopular financial etf poised for best daily gain since late june aelon musk mark zuckerberg spar on ai adebtceiling fears bubble up in treasury bills ajack bogle is right dont be a passive investor be a frugal investor asp  jumps to record on bullish earnings but alphabet weighs on nasdaq awti oil prices trade near the sessions highs on nymex asept wti oil climbs by  or  to bbl athe shockingly subdued vix doesn’t mean what you think it means atrump hammered on twitter over the tenor of his address to boy scouts loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert new york markets close in market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest psen angus king’s silent synopsis of the healthcare legislation up for vote today pgold extends declines to a second session as investors await fed update pcharting a slowmotion summer breakout sp  confirms bull trend pwhy vix is flirting with its lowest level in history and how wall street is reacting pthe highest paid athletes in the world in one chart peuropean stocks finish higher as german businesses take ‘euphoric’ tone pbrits don’t want america’s chlorinated chickens in their supermarkets pdebtceiling fears bubble up in treasury bills ahere’s one trump fan who might make you some money aftse  ends higher as commodity stocks climb factory production roars athis quant pro and card counter says gambling can make you a better investor apopular financial etf poised for best daily gain since late june aelon musk mark zuckerberg spar on ai adebtceiling fears bubble up in treasury bills ajack bogle is right dont be a passive investor be a frugal investor asp  jumps to record on bullish earnings but alphabet weighs on nasdaq awti oil prices trade near the sessions highs on nymex asept wti oil climbs by  or  to bbl athe shockingly subdued vix doesn’t mean what you think it means atrump hammered on twitter over the tenor of his address to boy scouts loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  lptx stock price  leap therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers fcx  rrc  nem  sig  stx  ipg  wat  mmm  latest newsall times eastern p updated sen angus king’s silent synopsis of the healthcare legislation up for vote today p updated gold extends declines to a second session as investors await fed update p charting a slowmotion summer breakout sp  confirms bull trend p updated why vix is flirting with its lowest level in history and how wall street is reacting p the highest paid athletes in the world in one chart p updated european stocks finish higher as german businesses take ‘euphoric’ tone p updated brits don’t want america’s chlorinated chickens in their supermarkets p debtceiling fears bubble up in treasury bills a opinion here’s one trump fan who might make you some money a updated ftse  ends higher as commodity stocks climb factory production roars to be replaced home investing quotes stocks united states lptx overview compare quotes stock screener earnings calendar sectors nasdaq lptx us nasdaq join td ameritrade find a broker leap therapeutics inc watchlist createlptxalert open last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps na yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  recent news marketwatch other dow jones leap therapeutics started at buy with  stock price target at ladenburg thalmann mar   at  am et by tomi kilgore no headlines available recent news other news press releases leap therapeutics to explore the potential of dknkeytruda combo in treatment resistant esophagogastric cancers shares ahead  leap therapeutics to explore the potential of dknkeytruda combo in treatment resistant esophagogastric cancers shares ahead  jun   at  am et on seeking alpha leap therapeutics lptx presents at jefferies  global healthcare conference  slideshow leap therapeutics lptx presents at jefferies  global healthcare conference  slideshow jun   at  pm et on seeking alpha  things in biotech you should learn today may    things in biotech you should learn today may   may   at  pm et on seeking alpha q leap therapeutics inc q leap therapeutics inc may   at  am et on edgar online  edg  q k k leap therapeutics inc mar   at  pm et on edgar online  edg  q k premarket analyst action  healthcare mar   at  am et on seeking alpha leap therapeutics added to russell microcapr index leap therapeutics added to russell microcapr index jun   at  am et on globenewswire leap therapeutics announces collaboration with merck to evaluate keytrudar pembrolizumab in combination with dkn in esophagogastric cancer leap therapeutics announces collaboration with merck to evaluate keytrudar pembrolizumab in combination with dkn in esophagogastric cancer jun   at  am et on globenewswire leap therapeutics to present at two investor conferences in june leap therapeutics to present at two investor conferences in june jun   at  am et on globenewswire leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asco  annual meeting leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asco  annual meeting may   at  pm et on globenewswire leap therapeutics reports first quarter  financial results leap therapeutics reports first quarter  financial results may   at  am et on globenewswire leap therapeutics to present dkn clinical data at american society of clinical oncology asco  annual meeting apr   at  pm et on globenewswire leap therapeutics presents nonclinical and phase  data for trx and dkn at the  aacr annual meeting apr   at  am et on globenewswire leap therapeutics reports full year  financial results and progressionfree survival data in advanced biliary tract cancers mar   at  pm et on globenewswire leap therapeutics to present at two investor conferences in april mar   at  am et on globenewswire leap therapeutics to present at  barclays global healthcare conference mar   at  am et on globenewswire leap therapeutics to present preclinical and clinical data at  aacr annual meeting mar   at  pm et on globenewswire leap therapeutics to present at th annual bio ceo  investor conference feb   at  am et on globenewswire leap therapeutics presents biomarker and efficacy data at the cholangiocarcinoma foundation  annual meeting feb   at  am et on globenewswire leap therapeutics and macrocure complete merger transaction jan   at  am et on globenewswire macrocure and leap therapeutics complete merger jan   at  am et on pr newswire  prf leap therapeutics presents biomarker data from clinical study of dkn in combination with paclitaxel in esophageal cancer jan   at  pm et on globenewswire leap therapeutics inc engages in clinical stage immunooncology see full profile benzingas top upgrades downgrades for march   mar   at  am et on benzingacom benzingas top upgrades downgrades for march   mar   at  am et on benzingacom partner content trending tickers powered by aks  goog  snap  fcx  dwt  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience leap therapeutics inc lptxa company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile leap therapeutics inc lptxa related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse lptxa on american stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description leap therapeutics inc formerly healthcare pharmaceuticals inc is a clinicalstage biopharmaceutical company the company engages in acquiring and developing therapeutics in cancer biology leaps programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the bodys immune system to identify and attack cancer the companys lead product candidates for use in clinical trials include trx and dkn dkn is a monoclonal antibody targeting dickkopfrelated protein  dkk dkk serves as the inhibitors of the canonical wnt signaling pathway and modulates the noncanonical wnt signaling pathways when dkn binds to dkk wnt signaling pathways and the tumor microenvironment are altered and an antitumor effect can be generated the company is testing dkn in ongoing clinical trials in patients with esophageal cancer in combination with paclitaxel and in patients with cholangiocarcinoma in combination with gemcitabine and cisplatin the company has studied dkn as a monotherapy in patients with nonsmall cell lung cancer nsclc dknbased therapies have generated responses and clinical benefit in these patient populationsdkn has potential as a targeted cancer treatment in other tumor types such as pancreatic gastric liver head and neck uterine and prostate cancers and multiple myeloma dkn has been tested as a monotherapy in patients with nsclc and in a pilot study in patients with multiple myeloma in combination with lenalidomide and dexamethasone trx is a monoclonal antibody targeting the glucocorticoidinduced tumor necrosis factorrelated receptor gitr a receptor found on the surface of a range of immune cells trx has been engineered to enhance the immune systems antitumor response by activating gitr signaling or gitr agonism to activate tumor fighting white blood cells or t effector cells and decrease the activity of potentially tumorprotective white blood cells or t regulatory cells without causing the immune cells to be destroyed the company is conducting two clinical trials of trx in patients with advanced solid tumors and have evidence of biomarker modulation and clinical activitythe company competes with novartis ag merck  co pfizer inc bristolmyers squibb company astrazeneca plc agenus inc and incyte corporation » full overview of lptxa company address leap therapeutics inc  thorndike st ste bcambridge   ma    p f  company web links home page officers  directors » more officers  directors leap therapeutics inc news briefleap therapeutics says merck will sponsor and fund initial trials of their combo drug study jun   briefleap therapeutics announces collaboration with merck jun   » more lptxa news related topics stocksstock screenerhealthcarebiotechnology  medical research leap therapeutics inc lptx leap therapeutics inc lptx product news news  stocknewscom     follow us stocktwits twitter leap therapeutics inc lptx product news news lptx – company to investigate its dkk antagonist dkn in combination w merck’s keytruda in patients with relapsed or refractory advanced esophagogastric cancers study is expected to begin enrolling patients in h jun    am  by stocknewscom staff product news key facts surrounding this news item lptx had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about leap therapeutics inc lptx leap therapeutics inc a clinicalstage biopharmaceutical company engages in acquiring and developing therapeutics in cancer biology the company was formerly known as healthcare pharmaceuticals inc and changed its name to leap therapeutics inc in november  leap therapeutics inc was founded in  and is based in cambridge massachusetts view our full lptx ticker page with ratings news and more lptx at a glance lptx current powr rating™ overall powr rating™ lptx current price   more lptx ratings data and news lptx price reaction the day of this event jun  lptx closing price lptx volume from avgleading up to this eventlptx mo returnnaafter this eventlptx day returnlptx day returnlptx day return lptx price chart more leap therapeutics inc lptx news view all eventdate symbol news detail start price end price change powr rating loading please wait view all lptx news page generated in  seconds pipeline  esophageal cancer  cholangiocarcinoma  leap therapeutics two firstinclass clinicalstage antibodies leap therapeutics’ lead clinical candidate dkn is a humanized monoclonal antibody targeting the dickkopf dkk protein and is currently being studied in clinical trials in esophageal cancer and cholangiocarcinoma a form of bile duct cancer our lead indication esophageal cancer is an aggressive disease with  patients diagnosed annually in the us and  diagnosed worldwide more than  of patients present with advanced disease with an expected survival of only  months there are no approved therapies for relapsed or refractory disease of the esophagus on june   leap presented data from its ongoing biliary tract cancer trial at the asco annual meeting click here to view our poster on january   leap presented biomarker and efficacy data from its ongoing esophageal cancer trial at the asco gi meeting click here to view our poster on april   leap presented nonclinical and clinical data at the aacr annual meeting click here to view our poster   leap therapeutics’ second clinical candidate trx is a novel humanized antigitr glucocorticoidinduced tumor necrosis factor receptor monoclonal antibody designed to enhance the immune system’s antitumor response as an immune checkpoint agonist trx is currently in phase  clinical trials in solid tumor malignancies on june th  leap presented early data from its single dose dose escalation study in solid tumors at the asco annual meeting click here to view our poster dknantidkk antibody esophageal cancer      cholangiocarcinoma      nonsmall cell lung cancer      indication trxantigitr antibody solid tumor malignancies      indication home about management board of directors scientific advisory board pipeline science modulate wnt signaling immunooncology publications for patients investors stock information stock quote  chart historical price lookup news  events news releases events calendar financial information corporate governance documents management board of directors committee composition investor resources information request careers contact about management board of directors scientific advisory board pipeline science modulate wnt signaling immunooncology publications for patients investors stock information stock quote  chart historical price lookup news  events news releases events calendar financial information corporate governance documents management board of directors committee composition investor resources information request careers contact   leap therapeutics incall rights reservedwebsite design hane chow inc leap therapeutics added to russell microcap® index nasdaqlptx english français register sign in leap therapeutics added to russell microcap® index june    et  source leap therapeutics cambridge mass june   globe newswire  leap therapeutics inc nasdaqlptx a biotechnology company developing targeted and immunooncology therapeutics today announced that it was added to the russell microcap® index when the russell investment group reconstituted its family of us indexes effective today june   membership in the russell microcap index which remains in place for one year means automatic inclusion in the appropriate growth and value style indexes ftse russell determines membership for its russell indices primarily by objective marketcapitalization rankings and style attributes about leap therapeuticsleap therapeutics’ nasdaqlptx most advanced clinical candidate dkn is a humanized monoclonal antibody targeting the dickkopf dkk protein dkn is in clinical trials in patients with gastroesophageal cancer alone and in combination with paclitaxel and in patients with biliary tract cancer in combination with gemcitabine and cisplatin an investigatorinitiated study of dkn will be conducted in hepatocellular carcinoma patients in combination with sorafenib  dkn has demonstrated single agent activity in nonsmall cell lung cancer patients leap’s second clinical candidate trx is a novel humanized gitr agonist monoclonal antibody designed to enhance the immune system’s antitumor response that is in two monotherapy studies  for more information about leap therapeutics visit httpwwwleaptxcom or our public filings with the sec that are available via edgar at httpwwwsecgov or via httpwwwinvestorsleaptxcom forward looking statements this press release contains forwardlooking statements within the meaning of section a of the securities act of  section e of the securities exchange act of  and the private securities litigation reform act of  which involve risks and uncertainties these statements include statements relating to leap’s expectations with respect to the development and advancement of dkn trx and other programs including the initiation timing and design of future studies enrollment in future studies business development and other future expectations plans and prospects leap has attempted to identify forward looking statements by such terminology as ‘‘believes’’ ‘‘estimates’’ ‘‘anticipates’’ ‘‘expects’’ ‘‘plans’’ ‘‘projects’’ ‘‘intends’’ ‘‘may’’ ‘‘could’’ ‘‘might’’ ‘‘will’’ ‘‘should’’ or other words that convey uncertainty of future events or outcomes to identify these forwardlooking statements although leap believes that the expectations reflected in such forwardlooking statements are reasonable as of the date made forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations these risks and uncertainties include but are not limited to the outcome cost and timing of our product development activities and clinical trials the uncertain clinical development process including the risk that clinical trials may not have an effective design or generate positive results our ability to obtain and maintain regulatory approval of our drug product candidates our plans to research develop and commercialize our drug product candidates our ability to achieve market acceptance of our drug product candidates unanticipated costs or delays in research development and commercialization efforts the applicability of clinical study results to actual outcomes the size and growth potential of the markets for our drug product candidates the accuracy of our estimates regarding expenses future revenues capital requirements and needs for financing our ability to continue obtaining and maintaining intellectual property protection for our drug product candidates and other risks detailed information regarding factors that may cause actual results to differ materially will be included in leap therapeutics’ periodic filings with the securities and exchange commission the sec including leap therapeutics’ form k that leap filed with the sec on march   these statements are only predictions and involve known and unknown risks uncertainties and other factors any forward looking statements contained in this release speak only as of its date we undertake no obligation to update any forwardlooking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events contact douglas e onsi chief financial officer leap therapeutics inc donsileaptxcom  argot partners susan kim  susanargotpartnerscom or heather savelle  heatherargotpartnerscom related articles other press releases by leap therapeutics leap therapeutics announces collaboration with merck to evaluate keytruda® pembrolizumab in combination with dkn in esophagogastric cancer june    leap therapeutics to present at two investor conferences in june june    leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asco  annual meeting may    leap therapeutics reports first quarter  financial results may    leap therapeutics to present dkn clinical data at american society of clinical oncology asco  annual meeting april    profile leap therapeutics   subscribe via rss  subscribe via atom  javascript cambridge massachusetts united states contact data contact douglas e onsi chief financial officer leap therapeutics inc donsileaptxcom  argot partners susan kim  susanargotpartnerscom or heather savelle  heatherargotpartnerscom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files leap therapeutics logo logo url  copy the link below formats available original medium small newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved leap therapeutics to present at two investor conferences in june nasdaqlptx english français register sign in leap therapeutics to present at two investor conferences in june june    et  source leap therapeutics cambridge mass june   globe newswire  leap therapeutics inc nasdaqlptx a biotechnology company developing targeted and immunooncology therapeutics today announced that christopher k mirabelli phd chairman president and chief executive officer will present at the jefferies  global healthcare conference dr mirabelli will also participate in a panel discussion entitled “immunooncology checkpoints as targets” at the jmp securities life sciences conference presentation details for both conferences are summarized below the presentation at the jefferies  global healthcare conference will be webcast live and may be accessed on the investors page of the company’s website at wwwinvestorsleaptxcom where a replay of the event will also be available for a limited time leap presentation details jefferies  global healthcare conference  date june   time  pm eastern time jmp securities life sciences conference date june  time  am eastern time about leap therapeuticsleap therapeutics’ nasdaqlptx most advanced clinical candidate dkn is a humanized monoclonal antibody targeting the dickkopf dkk protein dkn is in clinical trials in patients with gastroesophageal cancer alone and in combination with paclitaxel and in patients with biliary tract cancer in combination with gemcitabine and cisplatin an investigatorinitiated study of dkn will be conducted in hepatocellular carcinoma patients in combination with sorafenib  dkn has demonstrated single agent activity in nonsmall cell lung cancer patients leap’s second clinical candidate trx is a novel humanized gitr agonist monoclonal antibody designed to enhance the immune system’s antitumor response that is in two monotherapy studies  for more information about leap therapeutics visit httpwwwleaptxcom or our public filings with the sec that are available via edgar at httpwwwsecgov or via httpwwwinvestorsleaptxcom forward looking statements this press release contains forwardlooking statements within the meaning of section a of the securities act of  section e of the securities exchange act of  and the private securities litigation reform act of  which involve risks and uncertainties these statements include statements relating to leap’s expectations with respect to the development and advancement of dkn trx and other programs including the initiation timing and design of future studies enrollment in future studies business development and other future expectations plans and prospects leap has attempted to identify forward looking statements by such terminology as ‘‘believes’’ ‘‘estimates’’ ‘‘anticipates’’ ‘‘expects’’ ‘‘plans’’ ‘‘projects’’ ‘‘intends’’ ‘‘may’’ ‘‘could’’ ‘‘might’’ ‘‘will’’ ‘‘should’’ or other words that convey uncertainty of future events or outcomes to identify these forwardlooking statements although leap believes that the expectations reflected in such forwardlooking statements are reasonable as of the date made forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations these risks and uncertainties include but are not limited to the outcome cost and timing of our product development activities and clinical trials the uncertain clinical development process including the risk that clinical trials may not have an effective design or generate positive results our ability to obtain and maintain regulatory approval of our drug product candidates our plans to research develop and commercialize our drug product candidates our ability to achieve market acceptance of our drug product candidates unanticipated costs or delays in research development and commercialization efforts the applicability of clinical study results to actual outcomes the size and growth potential of the markets for our drug product candidates the accuracy of our estimates regarding expenses future revenues capital requirements and needs for financing our ability to continue obtaining and maintaining intellectual property protection for our drug product candidates and other risks detailed information regarding factors that may cause actual results to differ materially will be included in leap therapeutics’ periodic filings with the securities and exchange commission the sec including leap therapeutics’ form k that leap filed with the sec on march   these statements are only predictions and involve known and unknown risks uncertainties and other factors any forward looking statements contained in this release speak only as of its date we undertake no obligation to update any forwardlooking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated eventscontact douglas e onsi chief financial officer leap therapeutics inc donsileaptxcom  argot partners susan kim  susanargotpartnerscom or heather savelle  heatherargotpartnerscom related articles other press releases by leap therapeutics leap therapeutics added to russell microcap® index june    leap therapeutics announces collaboration with merck to evaluate keytruda® pembrolizumab in combination with dkn in esophagogastric cancer june    leap therapeutics presents positive dkn clinical data in biliary tract cancers at american society of clinical oncology asco  annual meeting may    leap therapeutics reports first quarter  financial results may    leap therapeutics to present dkn clinical data at american society of clinical oncology asco  annual meeting april     other news releases in calendar of events in the last  days profile leap therapeutics   subscribe via rss  subscribe via atom  javascript cambridge massachusetts united states contact data contact douglas e onsi chief financial officer leap therapeutics inc donsileaptxcom  argot partners susan kim  susanargotpartnerscom or heather savelle  heatherargotpartnerscom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files leap therapeutics logo logo url  copy the link below formats available original medium small newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved leap therapeutics  immunooncology leap therapeutics is a clinicalstage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research  view latest company presentation two firstinclass antibodies our most advanced clinical programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and proliferate known as cancer cell signaling and pathways that enable body’s immune system to identify and attack cancer learn more experienced leadership successful leadership and development team working together for over  years comprehensive experience acquiring and developing approved transformational therapies learn more recent news   more news for patients therapies targeting cancer cell signaling and t cells may offer new options for patients with cancer learn more about management board of directors scientific advisory board pipeline science modulate wnt signaling immunooncology publications for patients investors stock information stock quote  chart historical price lookup news  events news releases events calendar financial information corporate governance documents management board of directors committee composition investor resources information request careers contact about management board of directors scientific advisory board pipeline science modulate wnt signaling immunooncology publications for patients investors stock information stock quote  chart historical price lookup news  events news releases events calendar financial information corporate governance documents management board of directors committee composition investor resources information request careers contact   leap therapeutics incall rights reservedwebsite design hane chow inc bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one